<- Go Home
DA32 Life Science Tech Acquisition Corp.
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Market Cap
$264.7M
Volume
84.2K
Cash and Equivalents
$303.8K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$11.22
52 Week Low
$9.68
Dividend
N/A
Price / Book Value
-51.82
Price / Earnings
153.17
Price / Tangible Book Value
-51.82
Enterprise Value
$264.4M
Enterprise Value / EBITDA
N/A
Operating Income
-$1.8M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$303.8K
Debt
N/A
Equity
-$5.1M
Revenue
N/A
Unlevered FCF
N/A
Sector
Capital Markets
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium